Human serum albumin coated iron oxide nanoparticles for efficient celllabeling
- 12 November 2009
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 46 (3), 433-435
- https://doi.org/10.1039/b917195a
Abstract
A novel dopamine-plus-HSA (human serum albumin) approach was developed to functionalize iron oxide nanoparticles (IONPs), yielding nanoconjugates that are highly efficient in labeling various types of cell lines, which was demonstrated by in vivo MR imaging on xenograft and focal cerebral ischemia models.This publication has 24 references indexed in Scilit:
- Cellular therapy to control tumor progressionCurrent Opinion in Hematology, 2009
- Feridex Preloading Permits Tracking of CNS-Resident Macrophages after Transient Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 2009
- Ultrasmall c(RGDyK)-Coated Fe3O4 Nanoparticles and Their Specific Targeting to Integrin αvβ3-Rich Tumor CellsJournal of the American Chemical Society, 2008
- Controlled Etching of Carbon Nanotubes by Iron‐Catalyzed Steam GasificationAdvanced Materials, 2007
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006
- MRI detection of macrophage activity after experimental stroke in rats: New indicators for late appearance of vascular degradation?Magnetic Resonance in Medicine, 2005
- Iron oxide MR contrast agents for molecular and cellular imagingNMR in Biomedicine, 2004
- Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissuesBlood, 2004
- Distribution of SPARC in normal and neoplastic human tissue.Journal of Histochemistry & Cytochemistry, 1995
- Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Stroke, 1992